|
On 22 November 2018, Hong Kong
Science and Technology Parks Corporation organized
a press-release for GeneHarbor to announce a full
chain of Enzymatic Technology for Bio-Manufacturing. Named Immobilised Enzyme Assembly for Cascade Biocatalysis, the biotech platform uses
newly-developed industrial enzymes, proprietary technologies and
groundbreaking enzyme-based manufacturing processes to develop drugs and
food ingredients for various industries. After the announcement, the
media visited GeneHarbor’s R&D centre at Hong
Kong Science Park.
|
|